Results 41 to 50 of about 9,263,948 (394)

Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors.

open access: yesBlood, 2002
The excess risk of second malignancy after Hodgkin disease is an increasing problem. In light of the long-term data, guidelines for follow-up of survivors of Hodgkin disease need to be redefined.
A. Ng   +9 more
semanticscholar   +1 more source

Incidental finding of lymphoma after septoplasty. [PDF]

open access: yes, 2016
IntroductionSeptoplasty, or surgical correction of the deviated septum, is an elective, routinely performed rhinologic procedure to address nasal airway obstruction.
Bhuta, Sunita M   +5 more
core   +2 more sources

Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma

open access: yesJournal of the National Cancer Institute, 2015
Background: Hodgkin lymphoma (HL) survivors are at increased risk for developing valvular heart disease (VHD). We evaluated the determinants of the risk and the radiation dose-response.
D. Cutter   +8 more
semanticscholar   +1 more source

Channel noise effects on neural synchronization [PDF]

open access: yes, 2020
Synchronization in neural networks is strongly tied to the implementation of cognitive processes, but abnormal neuronal synchronization has been linked to a number of brain disorders such as epilepsy and schizophrenia.
Lindenberg, Katja, Maisel, Brenton
core   +2 more sources

Monocyte-mediated inhibition of lymphocyte blastogenesis in Hodgkin disease

open access: yes, 1978
Mononuclear leukocytes isloated from the blood of previously treated patients with advanced active Hodgkin disease contained high concentrations of monocytes and showed poor lymphocyte blastogenesis to mitogens.
G. Schechter, F. Soehnlen
semanticscholar   +1 more source

Human leukocyte antigens and genetic susceptibility to lymphoma [PDF]

open access: yes, 2015
Familial aggregation, coupled with ethnic variation in incidence, suggests that inherited susceptibility plays a role in the development of lymphoma, and the search for genetic risk factors has highlighted the contribution of the human leukocyte antigen (
Jarrett, R.F., McAulay, K.A.
core   +1 more source

Alterations of Spermatozoa Proteomic Profile in Men with Hodgkin’s Disease Prior to Cancer Therapy

open access: yesThe World Journal of Men's Health, 2020
Purpose: Hodgkin’s disease (HD) is a type of cancer affecting men in the reproductive age with potential consequences on their fertility status. This study aims to analyze sperm parameters, alterations in proteomic profiles and validate selected protein
Ana D. Martins   +5 more
doaj   +1 more source

Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead [PDF]

open access: yes, 2015
Non-Hodgkin lymphoma is the fourth most common malignancy in children, has an even higher incidence in adolescents, and is primarily represented by only a few histologic subtypes. Dramatic progress has been achieved, with survival rates exceeding 80%, in
Auperin, Anne   +23 more
core   +1 more source

Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma [PDF]

open access: yes, 2016
Levels of plasma cell-free DNA (cfDNA) of a large series of children with classical Hodgkin lymphoma (cHL) were evaluated and analyzed at diagnosis and during chemotherapy treatment in relation with clinical characteristics.
Basso, Giuseppe   +11 more
core   +2 more sources

A case study evaluating deep inspiration breath‐hold and intensity‐modulated radiotherapy to minimise long‐term toxicity in a young patient with bulky mediastinal Hodgkin lymphoma

open access: yesJournal of Medical Radiation Sciences, 2017
Radiotherapy plays an important role in the treatment of early‐stage Hodgkin lymphoma, but late toxicities such as cardiovascular disease and second malignancy are a major concern.
Jonathan M. Tomaszewski   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy